Umbilical Mesenchymal Stromal Cells Therapy(Ottawa Hospital Research Institute)

N/A

Report date: 2025/03/28 15:54:21

Base Information

Drug NameUmbilical Mesenchymal Stromal Cells Therapy(Ottawa Hospital Research Institute)

Drug Alias NameAllogeneic Umbilical Cord-derived Human Mesenchymal Stromal Cells TherapyCellular Therapy(Ottawa Hospital Research Institute)Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Therapy(Ottawa Hospital Research Institute)Mesenchymal Stromal Cells Therapy(Ottawa Hospital Research Institute)Umbilical Mesenchymal Stromal Cells Therapy(Ottawa Hospital Research Institute)

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derivedCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsShockSystemic Inflammatory Response SyndromeInflammation +[8]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe Ottawa Hospital Research Institute

China Registration ClassN/A

Develop Information

Active CompaniesThe Ottawa Hospital Research Institute

Inactive CompaniesN/A

Active IndicationsShockSystemic Inflammatory Response SyndromeInflammation +[7]

Inactive IndicationsInfections

Other Information

ATC CodeN/A